These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 26404453

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The influence of lipophilicity in drug discovery and design.
    Arnott JA, Planey SL.
    Expert Opin Drug Discov; 2012 Oct; 7(10):863-75. PubMed ID: 22992175
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Improving compound quality through in vitro and in silico physicochemical profiling.
    van de Waterbeemd H.
    Chem Biodivers; 2009 Nov; 6(11):1760-6. PubMed ID: 19937820
    [Abstract] [Full Text] [Related]

  • 9. Renal clearance in drug discovery and development: molecular descriptors, drug transporters and disease state.
    Feng B, LaPerle JL, Chang G, Varma MV.
    Expert Opin Drug Metab Toxicol; 2010 Aug; 6(8):939-52. PubMed ID: 20433402
    [Abstract] [Full Text] [Related]

  • 10. Recent advances in physicochemical and ADMET profiling in drug discovery.
    Wang J, Skolnik S.
    Chem Biodivers; 2009 Nov; 6(11):1887-99. PubMed ID: 19937823
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Utility of protein structures in overcoming ADMET-related issues of drug-like compounds.
    Stoll F, Göller AH, Hillisch A.
    Drug Discov Today; 2011 Jun; 16(11-12):530-8. PubMed ID: 21554979
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The impact of physicochemical and molecular properties in drug design: navigation in the "drug-like" chemical space.
    Vallianatou T, Giaginis C, Tsantili-Kakoulidou A.
    Adv Exp Med Biol; 2015 Jun; 822():187-94. PubMed ID: 25416989
    [Abstract] [Full Text] [Related]

  • 16. Addressing toxicity risk when designing and selecting compounds in early drug discovery.
    Segall MD, Barber C.
    Drug Discov Today; 2014 May; 19(5):688-93. PubMed ID: 24451294
    [Abstract] [Full Text] [Related]

  • 17. Impact of preformulation on drug development.
    Bharate SS, Vishwakarma RA.
    Expert Opin Drug Deliv; 2013 Sep; 10(9):1239-57. PubMed ID: 23534681
    [Abstract] [Full Text] [Related]

  • 18. In silico physicochemical parameter predictions.
    Wenlock MC, Barton P.
    Mol Pharm; 2013 Apr 01; 10(4):1224-35. PubMed ID: 23305561
    [Abstract] [Full Text] [Related]

  • 19. ADMET--Fifth Annual SMi Conference.
    Comer JE.
    IDrugs; 2010 Sep 01; 13(9):610-4. PubMed ID: 20799141
    [Abstract] [Full Text] [Related]

  • 20. Ligand efficiency metrics in drug discovery: the pros and cons from a practical perspective.
    Cavalluzzi MM, Mangiatordi GF, Nicolotti O, Lentini G.
    Expert Opin Drug Discov; 2017 Nov 01; 12(11):1087-1104. PubMed ID: 28814111
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.